Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Jacquelynne Corey

Otolaryngology Burr Ridge, IL Medical Doctor

NPI 1437214269 CMS profile 518111

180 Harvester Dr Ste 110, Burr Ridge, IL 60527

Open in the dashboard

General payments

$8,181

185 records reported · program years 2019–2024

Research payments

$14,000

Paid to them · 1 record reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Jacquelynne Corey of Burr Ridge, IL is reported in the CMS Open Payments database as having received $8,181 across 185 general payments and $14,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Otolaryngology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $161 1
2023 General $937 37
2022 General $1,751 47
2022 Research $14,000 1
2021 General $583 32
2020 General $579 26
2019 General $4,170 42

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jacquelynne Corey
  • Otolaryngology median
  • Middle half of Otolaryngology
  • National median

In program year 2025, general payments to Jacquelynne Corey were reported at $0. Among 6,588 Otolaryngology profiles paid that year, the median was $317 and the middle half received between $125 and $815.

Show as a table
Year Jacquelynne Corey Otolaryngology median Middle half National median
2019 $4,170 $194 $82–$512 $163
2020 $579 $118 $42–$280 $114
2021 $583 $167 $63–$444 $132
2022 $1,751 $216 $84–$545 $149
2023 $937 $235 $93–$588 $160
2024 $161 $280 $111–$699 $164
2025 $0 $317 $125–$815 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. OptiNose US, Inc. $4,016 62 payments
  2. ALK-Abello, Inc $1,016 48 payments
  3. Aerin Medical Inc. $862 4 payments
  4. AstraZeneca Pharmaceuticals LP $485 12 payments
  5. Regeneron Healthcare Solutions, Inc. $467 11 payments
  6. Genzyme Corporation $421 18 payments
  7. GlaxoSmithKline, LLC. $370 15 payments
  8. Amgen Inc. $138 2 payments
  9. Stryker Corporation $100 3 payments
  10. Sanofi-Aventis U.S. LLC $99 1 payment
  11. Other $207 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $4,914 180 payments
  2. Honoraria $2,500 1 payment
  3. Consulting Fee $406 1 payment
  4. Education $197 2 payments
  5. Travel and Lodging $163 1 payment
Products named General payments · program years 2019–2024
  1. Xhance $4,016 62 payments
  2. Odactra $927 43 payments
  3. Grastek $780 39 payments
  4. Ragwitek $707 35 payments
  5. DUPIXENT Immunology $520 19 payments
  6. DUPIXENT Inflammation And Immunology $467 11 payments
  7. NUCALA $277 9 payments
  8. FASENRA $260 5 payments
  9. RHINAER STYLUS $161 1 payment
  10. VIVAER STYLUS $161 1 payment
  11. Other $856 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Aerin Medical Inc. $14,000 1 payment

Records

186 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Otolaryngology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record